Frontlight ResearchEarly access
Trial site
Orlando
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- High blood pressure4 trials
- Chronic kidney disease1 trial
- Crohn's disease1 trial
- Epilepsy1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 24 trials
- Phase 1/22 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Alnylam Pharmaceuticals5 trials
- Arvinas Inc.1 trial
- Jazz Pharmaceuticals1 trial
- Olema Pharmaceuticals, Inc.1 trial
- Shattuck Labs, Inc.1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
Completed
Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026